NIAID TTIPO’s extraordinary efforts in “COVID-19 Technologies Licensed Globally Through WHO Program” was recognized by the Licensing Executives Society (U.S.A. & Canada) in 2022 with a Deals of Distinction Award in the Industry-University-Government Interface Sector. This award acknowledged the collaborative efforts put forth by the WHO, Medicines Patent Pool (MPP) and the NIH for COVID-19 technologies licensed globally through the WHO program. The technologies licensed included the stabilized spike protein used in currently available COVID-19 vaccines, research tools for vaccine, drug, and diagnostic development as well as early-stage vaccine candidates and diagnostics. Technologies developed by scientists from NCI, NEI, NIAID, NIEHS and NCATS became more accessible for people living in low-and middle-income countries.  

LES is a member society of the Licensing Executives Society International, Inc. (LESI), which has 32 sister societies representing the largest global network of licensing professionals. LES is the leading association for industrial intellectual property, technology, and business development professionals in the U.S. and Canada.